153 related articles for article (PubMed ID: 35290844)
1. Scaffold hopping of celastrol provides derivatives containing pepper ring, pyrazine and oxazole substructures as potent autophagy inducers against breast cancer cell line MCF-7.
Feng Y; Zhang B; Lv J; Zhang P; Mao Q; Lin F; Zhao J; Fu X; Yang Y; Li Z; Zhang L; Mou Y; Wang S
Eur J Med Chem; 2022 Apr; 234():114254. PubMed ID: 35290844
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of celastrol derivatives as potential anti-glioma agents by activating RIP1/RIP3/MLKL pathway to induce necroptosis.
Feng Y; Wang W; Zhang Y; Fu X; Ping K; Zhao J; Lei Y; Mou Y; Wang S
Eur J Med Chem; 2022 Feb; 229():114070. PubMed ID: 34968902
[TBL] [Abstract][Full Text] [Related]
3. The Synergistic Effects of Celastrol in combination with Tamoxifen on Apoptosis and Autophagy in MCF-7 Cells.
Wang L; Tang L; Yao C; Liu C; Shu Y
J Immunol Res; 2021; 2021():5532269. PubMed ID: 34337076
[TBL] [Abstract][Full Text] [Related]
4. 3-Aminomethyl pyridine chalcone derivatives: Design, synthesis, DNA binding and cytotoxic studies.
Durgapal SD; Soni R; Umar S; Suresh B; Soman SS
Chem Biol Drug Des; 2018 Jul; 92(1):1279-1287. PubMed ID: 29575807
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of ring-A modified lupeol derivatives and their anti-proliferative activity: identification of potent lead active against MCF-7 breast cancer cells.
Narendar K; Mandha Chander P; Abhisheik Eedara C; Andugulapati SB; Ramalingam V; SureshBabu K; Vijayachari P
Nat Prod Res; 2024; 38(2):304-310. PubMed ID: 36083601
[TBL] [Abstract][Full Text] [Related]
6. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
[TBL] [Abstract][Full Text] [Related]
7. Apogossypolone induces autophagy and apoptosis in breast cancer MCF-7 cells in vitro and in vivo.
Niu X; Li S; Wei F; Huang J; Wu G; Xu L; Xu D; Wang S
Breast Cancer; 2014 Mar; 21(2):223-30. PubMed ID: 22711315
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological activity evaluation of novel scopoletin-NO donor derivatives against MCF-7 human breast cancer in vitro and in vivo.
Yu N; Li N; Wang K; Deng Q; Lei Z; Sun J; Chen L
Eur J Med Chem; 2021 Nov; 224():113701. PubMed ID: 34315044
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative Phenothiazine Hybrids as Novel Apoptosis Inducers against MCF-7 Breast Cancer.
Zhang JX; Guo JM; Zhang TT; Lin HJ; Qi NS; Li ZG; Zhou JC; Zhang ZZ
Molecules; 2018 May; 23(6):. PubMed ID: 29843370
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, structural characterization, and anticancer activity of a monobenzyltin compound against MCF-7 breast cancer cells.
Fani S; Kamalidehghan B; Lo KM; Hashim NM; Chow KM; Ahmadipour F
Drug Des Devel Ther; 2015; 9():6191-201. PubMed ID: 26648695
[TBL] [Abstract][Full Text] [Related]
11. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of new sarsasapogenin derivatives with cytotoxicity and apoptosis-inducing activities in human breast cancer MCF-7 cells.
Wang W; Wang D; Wang Z; Yao G; Li X; Gao P; Li L; Zhang Y; Wang S; Song S
Eur J Med Chem; 2017 Feb; 127():62-71. PubMed ID: 28038327
[TBL] [Abstract][Full Text] [Related]
13. Design and molecular modeling of novel P38α MAPK inhibitors targeting breast cancer, synthesized from oxygen heterocyclic natural compounds.
Abdelhafez OM; Ahmed EY; Abdel Latif NA; Arafa RK; Abd Elmageed ZY; Ali HI
Bioorg Med Chem; 2019 Apr; 27(7):1308-1319. PubMed ID: 30792101
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of thienopyrimidine urea derivatives with potential cytotoxic and pro-apoptotic activity against breast cancer cell line MCF-7.
Abdelhaleem EF; Abdelhameid MK; Kassab AE; Kandeel MM
Eur J Med Chem; 2018 Jan; 143():1807-1825. PubMed ID: 29133058
[TBL] [Abstract][Full Text] [Related]
15. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
16. VEGFR-2 inhibiting effect and molecular modeling of newly synthesized coumarin derivatives as anti-breast cancer agents.
Ahmed EY; Abdel Latif NA; El-Mansy MF; Elserwy WS; Abdelhafez OM
Bioorg Med Chem; 2020 Mar; 28(5):115328. PubMed ID: 31992477
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
[TBL] [Abstract][Full Text] [Related]
18. A new synthetic HDAC inhibitor, MHY218, induces apoptosis or autophagy-related cell death in tamoxifen-resistant MCF-7 breast cancer cells.
Park JH; Ahn MY; Kim TH; Yoon S; Kang KW; Lee J; Moon HR; Jung JH; Chung HY; Kim HS
Invest New Drugs; 2012 Oct; 30(5):1887-98. PubMed ID: 21983700
[TBL] [Abstract][Full Text] [Related]
19. Dihydrotriazine derivatives display high anticancer activity and inducing apoptosis, ROS, and autophagy.
Zhang TY; Bai XQ; Zhou ZJ; Jin LH; Zhao DH; Sun SM
Bioorg Chem; 2022 Jul; 124():105813. PubMed ID: 35447405
[TBL] [Abstract][Full Text] [Related]
20. Flavokawain derivative FLS induced G2/M arrest and apoptosis on breast cancer MCF-7 cell line.
Ali NM; Akhtar MN; Ky H; Lim KL; Abu N; Zareen S; Ho WY; Alan-Ong HK; Tan SW; Alitheen NB; Ismail JB; Yeap SK; Kamarul T
Drug Des Devel Ther; 2016; 10():1897-907. PubMed ID: 27358555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
